Drug intelligence / Profile preview

Aldevit

Development stage: Unknown
Lead developer: Alde Medi Impex
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Oral

Overview

Aldevit is an oral nutraceutical product developed and marketed by Allde Medi Impex. It is formulated as a syrup containing a combination of protein, iron, zinc, and various minerals. The product is positioned as a dietary supplement to support general nutritional needs, particularly in cases of deficiency or increased physiological demand. As a multi-ingredient formulation, it provides essential macronutrients and micronutrients to support overall metabolic health, erythropoiesis (via iron), and immune function (via zinc). It is categorized as an over-the-counter (OTC) consumer product rather than a clinical-stage drug candidate.

Brand names: Aldevit
Other names: Aldevit Syrup

Beyond the preview

Go deeper on Aldevit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aldevit.

Explore the full profile